表紙
市場調査レポート

末梢動脈閉塞性疾患(PAOD):世界の治験レビュー

Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 315196
出版日 ページ情報 英文 85 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
末梢動脈閉塞性疾患(PAOD):世界の治験レビュー Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014
出版日: 2014年09月30日 ページ情報: 英文 85 Pages
概要

当レポートでは、末梢動脈閉塞性疾患(PAOD)に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 末梢動脈閉塞性疾患(PAOD)
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要5ヶ国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:心血管系疾患の治験件数に対する末梢動脈閉塞性疾患(PAOD)の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7カ国)での治験件数:心血管系疾患の治験件数に対する末梢動脈閉塞性疾患(PAOD)の治験件数比率

E7諸国(新興7カ国)での治験件数:フェーズ(相)別

E7諸国(新興7カ国)での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

一定期間に採用された被験者

スポンサーの種類別治験件数

有望なスポンサー

有望な薬剤

最新の治験情報

治験のプロファイル

  • 代表的な企業の治験概要
    • Sanofi
    • AstraZeneca PLC
    • Pfizer Inc.
    • AnGes MG, Inc.
    • Merck & Co., Inc.
    • Cytokinetics, Inc.
    • ZonMw
    • 日産化学工業
    • DNAVEC Corporation
    • F. Hoffmann-La Roche Ltd.
  • 代表的な大学・研究所における治験の概要
    • National Heart, Lung, and Blood Institute
    • University Hospital, Angers
    • Northwestern University
    • Medical University of Vienna
    • 小倉記念病院
    • 名古屋大学
    • University of California, San Francisco
    • Duke University
    • University of Virginia
    • The Cleveland Clinic

5つの代表的な治験のプロファイル

付録

図表一覧

目次

GlobalData's clinical trial report, "Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014" provides data on the Peripheral Artery Occlusive Disease (PAOD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Artery Occlusive Disease (PAOD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peripheral Artery Occlusive Disease (PAOD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Peripheral Artery Occlusive Disease (PAOD)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Peripheral Artery Occlusive Disease (PAOD) to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Peripheral Artery Occlusive Disease (PAOD) to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Peripheral Artery Occlusive Disease (PAOD)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AnGes MG, Inc.
      • Clinical Trial Overview of AnGes MG, Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Cytokinetics, Inc.
      • Clinical Trial Overview of Cytokinetics, Inc.
      • ZonMw
      • Clinical Trial Overview of ZonMw
      • Nissan Chemical Industries, Ltd.
      • Clinical Trial Overview of Nissan Chemical Industries, Ltd.
      • DNAVEC Corporation
      • Clinical Trial Overview of DNAVEC Corporation
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • University Hospital, Angers
      • Clinical Trial Overview of University Hospital, Angers
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Kokura Memorial Hospital
      • Clinical Trial Overview of Kokura Memorial Hospital
      • Nagoya University
      • Clinical Trial Overview of Nagoya University
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Duke University
      • Clinical Trial Overview of Duke University
      • University of Virginia
      • Clinical Trial Overview of University of Virginia
      • The Cleveland Clinic
      • Clinical Trial Overview of The Cleveland Clinic
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Peripheral Artery Occlusive Disease (PAOD) to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Peripheral Artery Occlusive Disease (PAOD) to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokinetics, Inc., 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nissan Chemical Industries, Ltd., 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by DNAVEC Corporation, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kokura Memorial Hospital, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014*

List of Figures

  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Peripheral Artery Occlusive Disease (PAOD) to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Peripheral Artery Occlusive Disease (PAOD) to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Peripheral Artery Occlusive Disease (PAOD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top